Sign in
OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia
Journal article

OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia

S.M.K. Farhan, T.F. Gendron, L. Petrucelli, R.A. Hegele and M.J. Strong
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol.177(1), pp.75-85
2018
PMID: 29080331

Abstract

Aged Amyotrophic Lateral Sclerosis Ataxin-2 C9orf72 Protein Cohort Studies Female Frontotemporal Dementia Genetic Predisposition to Disease Genetic Testing Humans Male Middle Aged Neurodegenerative Diseases Transcription Factor TFIIIA arginine ataxin 2 C9orf72 protein dipeptide methionine optineurin polyglutamine unclassified drug ataxin 2 ATXN2 protein, human C9orf72 protein, human guanine nucleotide exchange C9orf72 OPTN protein, human transcription factor IIIA adult aged Alzheimer disease amyotrophic lateral sclerosis Article ATXN2 gene behavior disorder C9orf72 gene clinical article cognitive defect disease course DNA modification female frontotemporal dementia genetic association genetic heterogeneity genetic screening genetic variation heterozygote human inheritance male next generation sequencing OPTN gene Parkinson disease phenotype priority journal amyotrophic lateral sclerosis case report cohort analysis degenerative disease frontotemporal dementia genetic predisposition genetics metabolism middle aged
url
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032304071&doi=10.1002%2fajmg.b.32606&partnerID=40&md5=b37948e72cd129eaef04e7ce0a410f59View

Metrics

1 Record Views
53 readers on Mendeley
1 readers on CiteULike

Details

Logo image